Would Hydroxychloroquine Be A New Promising
Drug in Managing Antiphospholipid Syndrome?

Amani Mohsen; Rabih Chahine

Email Us: info@lupinepublishers.com phone

Call Us: +1 (914) 407-6109 57 West 57th Street, 3rd floor, New York - NY 10019, USA

Submit Manuscript

ISSN: 2637-4706

Drug Designing & Intellectual Properties International Journal

Mini Review(ISSN: 2637-4706)

Would Hydroxychloroquine Be A New Promising Drug in Managing Antiphospholipid Syndrome?

Volume 2 - Issue 4

**Amani Mohsen¹* and Rabih Chahine²**

Author Information Open or Close
- ¹Obstetrics & gynecology consultant, Palestinian Red Crescent Society, Shatila Camp, Beirut, Lebanon
- ²chairman of obstetrics & gynecology department, Rafik Hariri university Hospital, Beirut, Lebanon
*Corresponding author: Amani Mohsen, Obstetrics & gynecology consultant, Palestinian Red Crescent Society, Shatila Camp, Beirut, Lebanon

Received:October 10, 2018; Published: October 15, 2018

DOI: 10.32474/DDIPIJ.2018.02.000141

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

Once Antiphospholipid syndrome (APS) is diagnosed, risk profile of the patient will impact its management whether there was a previous thrombotic event or not, association with other autoimmune disorders, presence of other obstetrical complications as well as being currently pregnant. The current recommended regimen for preventing obstetrical complications. The current recommended regimen for preventing obstetrical complications includes low molecular weight Heparin and low dose aspirin. This regimen decreases the risk of miscarriage by only 54%. Here, we will review the studies that evaluated adding Hydroxychloroquine (HCQ) to the treatment of APS and how effective it would be.

Keywords: Antiphospholipid syndrome; Hydroxychloroquine; Miscarriage

Abstract| Introduction| Refernces|

Editorial Manager:

Christine Timothy

Email:

drug@lupinepublishers.com

drug@lupinepublisher.co

Track Your Article

Top Editors

Mark E Smith

Bio chemistry
University of Texas Medical Branch, USA
Lawrence A Presley

Department of Criminal Justice
Liberty University, USA
Thomas W Miller

Department of Psychiatry
University of Kentucky, USA
Gjumrakch Aliev

Department of Medicine
Gally International Biomedical Research & Consulting LLC, USA
Christopher Bryant

Department of Urbanisation and Agricultural
Montreal university, USA
Robert William Frare

Oral & Maxillofacial Pathology
New York University, USA
Rudolph Modesto Navari

Gastroenterology and Hepatology
University of Alabama, UK
Andrew Hague

Department of Medicine
Universities of Bradford, UK
George Gregory Buttigieg

Maltese College of Obstetrics and Gynaecology, Europe
Chen-Hsiung Yeh

Oncology
Circulogene Theranostics, England
Emilio Bucio-Carrillo

Radiation Chemistry
National University of Mexico, USA
Casey J Grenier

Analytical Chemistry
Wentworth Institute of Technology, USA
Hany Atalah

Minimally Invasive Surgery
Mercer University school of Medicine, USA
Abu-Hussein Muhamad

Pediatric Dentistry
University of Athens , Greece